| BICYCLE THERAPEUTICS ADR |
| USA |
| Gesundheit |
| US0887861088 / A2PKZC |
| 50BA (Frankfurt) / BCYC (NASDAQ) |
| FRA:50BA, ETR:50BA, 50BA:GR, NASDAQ:BCYC |
| - |
| https://www.bicycletherap.. |
|
Bicycle Therapeutics plc - ADR is a clinical-stage biopharmaceutical company focused on developing a novel class of medicines known as Bicycle molecules. The company applies its proprietary bicyclic peptide platform to create targeted therapies desig..
>Volltext.. |
| 248.69 Mio. EUR |
| -190.89 Mio. EUR |
| 54.24 Mio. EUR |
| -205.52 Mio. EUR |
| -168.79 Mio. EUR |
| -2.43 EUR |
| 13.51 Mio. EUR |
| 453.1 Mio. EUR |
| -182.32 Mio. EUR |
| 10.71 |
| 215.59% |
| 22.01% |
| - |
| - |
| - |
| - |
| BICYCLE THERAPEUTICS, BICYCLE THERAPEUTIC |
| 07.10.26 |
|